Samil Pharmaceutical Co.,Ltd (KRX:000520)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical	210.25B	219.70B	196.35B	179.68B	134.25B
Pharmaceutical Growth	-4.30%	11.89%	9.28%	33.84%	9.14%
Total	210.25B	219.70B	196.35B	179.68B	134.25B
Total Growth	-4.30%	11.89%	9.28%	33.84%	9.14%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea	209.59B	217.52B	194.93B	178.83B	133.73B
South Korea Growth	-3.65%	11.59%	9.00%	33.72%	10.28%
Export	665.37M	2.18B	1.42B	842.66M	514.49M
Export Growth	-69.46%	53.48%	68.47%	63.78%	-70.33%
Total	210.25B	219.70B	196.35B	179.68B	134.25B
Total Growth	-4.30%	11.89%	9.28%	33.84%	9.14%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 14, 2026

Data Sources Report a data error